Dolutegravir

Published November 04, 2012
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-03
Selected Reference
1. Raffi F, Rachlis A, Stellbrink HJ, et al; SPRING-2 Study Group. Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study. Lancet. 2013 Mar 2;381(9868):735-43.